Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic ...

April 1, 2025 – Advances in breast cancer screening and treatment have saved a lot of lives over the past few decades – for some groups more than others. Overall, the number of Americans ...

The innovative approach targets human epidermal growth factor receptor 2-positive, estrogen receptor-negative (HER2-positive, ER-negative) breast cancer and has shown encouraging results in a ...

San Antonio Breast Cancer Symposium 2024 provided multiple updates in the field of HER2-positive breast cancer, including novel treatments, new treatment regimens and more. See Healio’s ...

With the addition of a new treatment option for a new molecularly defined type of breast cancer, "it is critical for patients to understand the HER2 status of their metastatic breast cancer to ...

Trastuzumab deruxtecan is approved for HR-positive, HER2-low/ultralow metastatic breast cancer post-endocrine therapy, based on DESTINY-Breast06 trial results. The trial showed a 36% reduction in ...

Although CDK4/6 inhibitors such as Ibrance are well-established treatments for HR-positive, HER2-negative breast cancer, a phase 3 trial sponsored by the cancer research organization Alliance ...

“Baywatch” star Nicole Eggert, 52, is prepping for radiation treatment in her battle against stage 2 cribriform carcinoma breast cancer, and she recently took ... The same approach is taken to hormone ...

HER2-positive (HER2+) breast cancer ... during and after cancer treatment. Areas of your skin could turn darker (hyperpigmentation), or red, or take on shades of black, blue, green, or yellow.